Document Type

Patent

Publication Date

1-7-2016

Patent Number

20160000866

Abstract

The invention features compositions and methods for treating and preventing steatosis, osteoporosis, and muscle weakness featuring the receptor for the collagen triple helix repeat containing-1 (Cthrc1) protein.

Application Number

14789479

Institution/Department

Maine Medical Center

Assignees

MaineHealth Insitute for Research

Filing Date

07/01/2015

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.